logo

DERM

Journey Medical·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

DERM fundamentals

Journey Medical (DERM) released its earnings on Nov 12, 2025: revenue was 17.60M (YoY +20.31%), missed estimates; EPS was -0.09 (YoY +25.00%), missed estimates.
Revenue / YoY
17.60M
+20.31%
EPS / YoY
-0.09
+25.00%
Report date
Nov 12, 2025
DERM Earnings Call Summary for Q3,2025
  • Amrosi Dominance: Q3 revenue up 75% QoQ, with 146% prescription growth and 1:1 refill rate, signaling strong patient adherence.
  • Financial Turnaround: EBITDA loss halved YoY, with $24.9M cash, setting up for Q4 EBITDA positivity.
  • Payer Expansion: 2026 GPO contracts to reduce reliance on copay program, driving revenue growth.
  • Operational Efficiency: 9% OpEx growth vs. 21% revenue growth, highlighting margin expansion potential.
EPS
Revenue

Revenue & Expenses

DERM has released its 2025 Q3 earnings report, with revenue of 17.63M, reflecting a YoY change of 20.52%, and net profit of -2.31M, showing a YoY change of 3.14%. The Sankey diagram below clearly presents DERM's revenue sources and cost distribution.

Key Indicators

Journey Medical (DERM) key financial stats and ratios, covering profitability, financial health, and leverage.
Journey Medical (DERM)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Journey Medical (DERM)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Journey Medical (DERM)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Journey Medical (DERM) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Journey Medical (DERM) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield